Deeter Investments »

Protagonist Therapeutics shares owned by Deeter Investments

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Deeter Investments from 13F filings

Historical chart of Deeter Investments investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Deeter Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Deeter Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 300k 9.55

More positions owned by Deeter Investments

Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Micron Technology (MU)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Adobe Systems Incorporated (ADBE)
Quanta Services (PWR)
Vale S A Sponsored Ads (VALE)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Ge Vernova (GEV)
Ishares Tr China Lg-cap Etf (FXI)
Alibaba Group Hldg Sponsored Ads (BABA)
Western Digital (WDC)
Nextera Energy (NEE)

View all positions for Deeter Investments

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
UBS Group
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics